Pretreatment CALLY index as promising novel biomarker in the prediction of surgical and oncological outcomes in esophageal cancer: a multi-center retrospective cohort study

Pretreatment CALLY index as promising novel biomarker in the prediction of surgical and oncological outcomes in esophageal cancer: a multi-center retrospective cohort study

BackgroundEsophageal cancer (EC) is a global health challenge with high mortality rates. The traditional TNM staging system is limited in its ability to provide accurate prognostic predictions. This study aimed to investigate the utility of the C-reactive protein-albumin-lymphocyte (CALLY) index in...

Full description

Saved in:
Bibliographic Details
Main Authors: Peize Meng, Tongtong Gu, Jiayong Xu, Haihua Huang, Hansong Jin, Yuchen Wang, Hang Zhang, Zheng Ruan
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Immunology
Subjects:
C-reactive protein-albumin-lymphocyte index
esophageal cancer
surgery
neoadjuvant therapy
overall survival
disease-free survival
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1605067/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items